FMP
Aclarion, Inc.
ACON
NASDAQ
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
6.79 USD
0.4 (5.89%)
Historical Prices
From:
To:
About
ceo
Mr. Brent Ness
sector
Healthcare
industry
Medical - Healthcare Information Services
website
https://www.aclarion.comexchange
NASDAQ
Description
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
CIK
0001635077
ISIN
US6551872012
CUSIP
655187409
Address
951 Mariners Island Boulevard
Phone
650-241-1741
Country
US
Employee
5
IPO Date
Apr 22, 2022
Financial Statement
Earnings
ACON Financial Summary
CIK
0001635077
Exchange
NASDAQ
Industry
Medical - Healthcare...
Sector
Healthcare
CUSIP
655187409
ISIN
US6551872012
Country
US
Price
6.79
Beta
1.08
Volume Avg.
217.03k
Market Cap
3.95M
Shares
-
52-Week
6.2-3500.415
DCF
-0.09
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-
P/B
-
Website
https://www.aclarion.com
Upgrades and Downgrades
We are unable to load the data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ACON News
Andrew Wynn
Mar 6, 2025
Recent Market Analysis Highlights Top Losers
In recent market analysis, several companies have emerged as top losers, experiencing significant price drops and volatility. Among these, Aclarion, Inc. (NASDAQ:ACON), CareCloud, Inc. (NASDAQ:CCLD), Elevai Labs, Inc. (ELAB), Scilex Holding Company (SCLXW), and Sleep Number Corporation (SNBR) have shown notable declines in their stock prices, according to the latest data. Aclarion, Inc. (ACON) has seen a dramatic decrease in its stock price, dropping by 74.13% to $1.8107, significantly below it...
GlobeNewsWire
Aug 15, 2024
Aclarion to Present at August 20th Virtual Investor Summit M...
BROOMFIELD, CO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that it will be presenting at the upcoming Virtual Investor Summit on August 20th, 2024. Investors may request a one-on-one meeting with management by registering here: https://investors...
InvestorPlace
Feb 26, 2024
Why Is Aclarion (ACON) Stock Down 19% Today?
Aclarion (NASDAQ: ACON ) stock is falling on Monday after the healthcare technology company revealed plans for a public offering of its shares. Aclarion intends to offer up to 3,888,888 units in this offering.
InvestorPlace
Jan 29, 2024
Why Is Aclarion (ACON) Stock Down 16% Today?
Aclarion (NASDAQ: ACON ) stock is falling on Monday after the healthcare technology company announced additional exchange agreements with accredited investors. According to a filing with the Securities and Exchange Commission (SEC), Aclarion issued 500,000 shares of ACON stock in exchange for $1,185,226 of principal and accrued interest on unsecured non-convertible notes.
PennyStocks
Apr 25, 2023
10 Top Penny Stocks To Watch Under $1
Penny stocks under $1 to watch this week. The post 10 Top Penny Stocks To Watch Under $1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Proactive Investors
Apr 24, 2023
Aclarion skyrockets on positive trial data for lower back pa...
Aclarion shares skyrocketed after the company published data from a two-year trial that demonstrated improved surgical outcomes for discogenic lower back pain (DLBP) surgeries at chemically painful lumbar discs identified by Nociscan, the company's intelligence platform for measuring pain biomarkers in the lumbar spine. Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine and uses its proprietary signal processing techniques to extract and quantify chemical biomarkers...
PennyStocks
Apr 24, 2023
Penny Stocks to Buy Now? 7 Under $1 To Watch This Week
Penny stocks to watch under $1 this week. The post Penny Stocks to Buy Now?
Newsfile Corp
Jan 17, 2023
Aclarion to Present at the Jan 26th Virtual Investor Summit ...
Broomfield, Colorado--(Newsfile Corp. - January 17, 2023) - Aclarion, Inc., (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that it will be presenting virtually at the upcoming Virtual Investor Summit on January 26th.Event: Q1 Investor SummitDate: January 26th, 2023Presentation: January 26...
